NCT00408330View on ClinicalTrials.gov

A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face

PHASE2CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Seborrheic Dermatitis on the Face

Interventions

DRUG

Azelaic Acid 15% Gel

15% gel, topically applied daily for six weeks

DRUG

Inactive 15% gel base

placebo, topically applied daily for six weeks

Trial Locations (4)

15831

Blankenfelde-Mahlow

20354

Hamburg

21244

Buchholz

22049

Hamburg

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

LEO Pharma

INDUSTRY